.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Candesartan cilexetil - Generic Drug Details

« Back to Dashboard
Candesartan cilexetil is the generic ingredient in four branded drugs marketed by Sandoz, Astrazeneca, Apotex Inc, Macleods Pharms Ltd, Mylan Labs, and Dr Reddys Labs Ltd, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for candesartan cilexetil. Eight suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: candesartan cilexetil

Tradenames:4
Patents:0
Applicants:6
NDAs:8
Drug Master File Entries: see list22
Suppliers / Packaging: see list8
Therapeutic Class:Cardiovascular Agents
Drug Prices:see low prices

Pharmacology for Ingredient: candesartan cilexetil

Tentative approvals for CANDESARTAN CILEXETIL

Applicant Application No. Form Dosage
<disabled><disabled>TABLET; ORAL16MG; 12.5MG
<disabled><disabled>TABLET; ORAL32MG; 12.5MG
<disabled><disabled>TABLET; ORAL32MG; 25MG

Clinical Trials for: candesartan cilexetil

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
ATACAND
candesartan cilexetil
TABLET;ORAL020838-002Jun 4, 1998RXNo
Mylan Labs
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL090704-002Dec 4, 2012RXNo
Apotex Inc
CANDESARTAN CILEXETIL
candesartan cilexetil
TABLET;ORAL202079-004Jan 10, 2014RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: candesartan cilexetil

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
ATACAND
candesartan cilexetil
TABLET;ORAL020838-002Jun 4, 19985,705,517*PED<disabled>
Astrazeneca
ATACAND
candesartan cilexetil
TABLET;ORAL020838-003Jun 4, 19987,538,133*PED<disabled>
Astrazeneca
ATACAND
candesartan cilexetil
TABLET;ORAL020838-002Jun 4, 19987,538,133*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc